World J Gastroenterol 2005, 11:875–879.PubMed Sotrastaurin concentration 10. Lee SO, Lou W, Qureshi KM, Mehraein-Ghomi F, Trump DL, Gao AC: RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells. Prostate 2004, 60:303–309.PubMedCrossRef 11. Zhang F, Li C, Halfter H, Liu J: Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells. Oncogene 2003, 22:894–905.PubMedCrossRef 12. Alvarez JV, Greulich H,

Sellers WR, Meyerson M, Frank DA: Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth selleck screening library factor receptor. Cancer Res 2006, 66:3162–3168.PubMedCrossRef 13. Shen Y, Devgan G, Darnell JE Jr, Bromberg JF: Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc Natl Acad Sci USA 2001, 98:1543–1548.PubMedCrossRef

14. Zamo A, Chiarle R, Piva R, Howes J, Fan Y, Chilosi M, et al.: Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene 2002, 21:1038–1047.PubMedCrossRef 15. Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM: Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res why 2003, 63:1270–1279.PubMed GW-572016 clinical trial 16. Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, et al.: Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer

Res 2002, 62:6659–6666.PubMed 17. Meydan N, Grunberger T, Dadi H, Shahar M, Arpaia E, Lapidot Z, et al.: Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 1996, 379:645–648.PubMedCrossRef 18. Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang QC, Zhang YJ, et al.: Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia 2008, 10:287–297.PubMed 19. Yang J, Liao X, Agarwal MK, Barnes L, Auron PE, Stark GR: Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev 2007, 21:1396–1408.PubMedCrossRef 20. Sekikawa A, Fukui H, Fujii S, Ichikawa K, Tomita S, Imura J, et al.: REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells. Carcinogenesis 2008, 29:76–83.PubMedCrossRef 21. Hodge DR, Hurt EM, Farrar WL: The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 2005, 41:2502–2512.PubMedCrossRef 22.